Firstcin


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 18.1%
Pneumonia 13.2%
Psoriatic Arthropathy 11.7%
Neoplasm Malignant 10.6%
Prophylaxis 9.4%
Pyrexia 5.4%
Infection 4.6%
Sepsis 3.3%
Antipyresis 2.8%
Hypertension 2.7%
Insomnia 2.5%
Infection Prophylaxis 2.2%
Nutritional Support 2.1%
B-cell Lymphoma 1.9%
Hepatitis C 1.8%
Deep Vein Thrombosis 1.5%
Depression 1.5%
Drug Use For Unknown Indication 1.5%
T-cell Type Acute Leukaemia 1.5%
Pain Prophylaxis 1.3%
Sepsis 10.7%
Hepatic Function Abnormal 8.0%
Histiocytosis Haematophagic 8.0%
Liver Disorder 6.7%
Pyrexia 6.7%
White Blood Cell Count Decreased 6.7%
Drug Rash With Eosinophilia And Systemic Symptoms 5.3%
Pancytopenia 5.3%
Vomiting 5.3%
Infection 4.0%
Pseudomembranous Colitis 4.0%
Rash Generalised 4.0%
Renal Cell Carcinoma 4.0%
Renal Cell Carcinoma Stage Iv 4.0%
White Blood Cell Disorder 4.0%
Cardiac Arrest 2.7%
Fall 2.7%
Interstitial Lung Disease 2.7%
Nikolsky's Sign 2.7%
Rash 2.7%
Concomitant
Product Used For Unknown Indication 16.6%
Prophylaxis 14.8%
Drug Use For Unknown Indication 14.1%
Pneumonia 6.3%
Infection Prophylaxis 5.9%
Infection 5.7%
Fluid Replacement 4.1%
Sedation 4.1%
Hypertension 3.4%
Multiple Myeloma 3.2%
Ureteral Stent Insertion 3.1%
Ureteral Stent Removal 3.1%
Pyrexia 2.8%
Cardiac Failure 2.1%
Diuretic Therapy 1.9%
Prophylaxis Against Graft Versus Host Disease 1.9%
Myelodysplastic Syndrome 1.8%
Insomnia 1.8%
Stem Cell Transplant 1.8%
Mycosis Fungoides 1.7%
White Blood Cell Count Decreased 19.2%
Respiratory Failure 8.8%
Pneumonia 8.0%
Sepsis 7.3%
Platelet Count Decreased 6.5%
Pyrexia 5.4%
Renal Impairment 5.0%
Interstitial Lung Disease 4.2%
Thrombocytopenia 4.2%
Serum Ferritin Increased 3.8%
Febrile Neutropenia 3.4%
White Blood Cell Count Increased 3.4%
Renal Disorder 3.1%
Vomiting 3.1%
Somnolence 2.7%
Tremor 2.7%
Death 2.3%
Diarrhoea 2.3%
Hepatic Function Abnormal 2.3%
Stomatitis 2.3%

Drug Data